9,10-Dimethyl-1,2-benzanthracene
"9,10-Dimethyl-1,2-benzanthracene" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
7,12-Dimethylbenzanthracene. Polycyclic aromatic hydrocarbon found in tobacco smoke that is a potent carcinogen.
| Descriptor ID |
D015127
|
| MeSH Number(s) |
D02.455.426.559.847.149.301 D04.615.149.301
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "9,10-Dimethyl-1,2-benzanthracene".
Below are MeSH descriptors whose meaning is more specific than "9,10-Dimethyl-1,2-benzanthracene".
This graph shows the total number of publications written about "9,10-Dimethyl-1,2-benzanthracene" by people in this website by year, and whether "9,10-Dimethyl-1,2-benzanthracene" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "9,10-Dimethyl-1,2-benzanthracene" by people in Profiles.
-
Chemically induced carcinogenesis in rodent models of aging: assessing organismal resilience to genotoxic stressors in geroscience research. Geroscience. 2019 04; 41(2):209-227.
-
DMBA promotes ErbB2-mediated carcinogenesis via ErbB2 and estrogen receptor pathway activation and genomic instability. Oncol Rep. 2018 Sep; 40(3):1632-1640.
-
Luteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley rats. Oncol Rep. 2016 Feb; 35(2):825-32.
-
[1,2-13C2]-D-glucose profiles of the serum, liver, pancreas, and DMBA-induced pancreatic tumors of rats. Pancreas. 2005 Nov; 31(4):337-43.
-
Induced antitumor immunity against DMBA-4 metastatic mammary tumors in rats using laser immunotherapy. Int J Cancer. 2003 Dec 20; 107(6):1053-7.
-
A rat model of syngeneic bone marrow transplantation during breast cancer therapy. Bone Marrow Transplant. 2003 Jun; 31(11):1037-41.
-
Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis. Endocrinology. 2002 Oct; 143(10):4139-42.
-
Prevention of rat mammary carcinoma utilizing leuprolide as an equivalent to oophorectomy. Breast Cancer Res Treat. 1999 Nov; 58(2):131-6.
-
Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen. Breast Cancer Res Treat. 1998 Jan; 47(1):63-70.
-
Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment. Cancer Lett. 1997 May 01; 115(1):25-30.